Evidence map›Paper›PMID 35272316›Full record

ReviewObstetrics and gynecology2022

Executive Summary of the Uterine Cancer Evidence Review Conference.

David Chelmow, Rebecca Brooks, Arjeme Cavens, Kathryn Huber-Keener, Dana M Scott, Sangini S Sheth, Sara Whetstone, Brett Worly, William Burke

Abstract readReview
In one paragraph

Review in Obstetrics and gynecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Endometrial Cancer Risk Among GermlineJCO precision oncology · 2023
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David ChelmowDepartments of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, University of California Davis Health System, Sacramento, California, Northwestern University Feinberg School of Medicine, Chicago, Illinois, University of Iowa Hospitals and Clinics, Iowa City, Iowa, University of Connecticut, Farmington, Connecticut, The Ohio State University Wexner College of Medicine, Columbus, Ohio, and Stony Brook University Hospital, Stony Brook, New York; and the Departments of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, and University of California San Francisco School of Medicine, San Francisco, California.
Rebecca Brooks
Arjeme Cavens
Kathryn Huber-Keener
Dana M Scott
Sangini S Sheth
Sara Whetstone
Brett Worly
William Burke

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Centers for Disease Control and Prevention recognized the need for educational materials for clinicians on the prevention and early diagnosis of gynecologic cancers. The American College of Obstetricians and Gynecologists convened a panel of experts in evidence review from the Society for Academic Specialists in General Obstetrics and Gynecology and content experts from the Society of Gynecologic Oncology to review relevant literature, best practices, and existing practice guidelines as a first step toward developing evidence-based educational materials for women's health care clinicians about uterine cancer. Panel members conducted structured literature reviews, which were then reviewed by other panel members and discussed at a virtual meeting of stakeholder professional and patient advocacy organizations in January 2021. This article is the evidence summary of the relevant literature and existing recommendations to guide clinicians in the prevention, early diagnosis, and special considerations of uterine cancer. Substantive knowledge gaps are noted and summarized to provide guidance for future research.

Indexed as

Genital Neoplasms, FemaleGynecologyObstetricsUterine NeoplasmsCongresses as TopicFemaleHumansPregnancyWomen's Health

Identifiers

PMID35272316
PMCPMC8936160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.